WuXi Biologics (Cayman) Inc. (HKG:2269)
30.82
+0.96 (3.22%)
Jun 18, 2026, 4:08 PM HKT
WuXi Biologics Employees
WuXi Biologics had 13,252 employees as of December 31, 2025. The number of employees increased by 677 or 5.38% compared to the previous year.
Employees
13,252
Change
677
Growth
5.38%
Revenue / Employee
1.83M HKD
Profits / Employee
412.17K HKD
Market Cap
127.40B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13,252 | 677 | 5.38% |
| Jun 30, 2025 | 12,552 | - | - |
| Dec 31, 2024 | 12,575 | -165 | -1.30% |
| Dec 31, 2023 | 12,740 | 367 | 2.97% |
| Dec 31, 2022 | 12,373 | 2,509 | 25.44% |
| Dec 31, 2021 | 9,864 | 3,218 | 48.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sino Biopharmaceutical | 21,435 |
| BeOne Medicines AG | 12,000 |
| Innovent Biologics | 7,502 |
| Genscript Biotech | 6,165 |
| 3SBio | 6,109 |
| Shanghai Henlius Biotech | 3,762 |
| Akeso | 3,761 |
| RemeGen | 3,048 |
WuXi Biologics News
- 2 days ago - WuXi Biologics' Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market - PRNewsWire
- 12 days ago - WuXi Biologics Ireland Wins Top Honors at the 2026 Life Sciences Industry Awards - PRNewsWire
- 16 days ago - WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility - PRNewsWire
- 18 days ago - WuXi Biologics Named to CDP Supplier Engagement Assessment A List for the Second Consecutive Year - PRNewsWire
- 19 days ago - WuXi Biologics Transcript: Investor update - Transcripts
- 19 days ago - WuXi Biologics Slides: Investor update - Filings
- 24 days ago - WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities - PRNewsWire
- 5 weeks ago - WuXi Biologics Included in 2026 Dow Jones Best‑in‑Class World Index and Emerging Markets Index - PRNewsWire